Alto Neuroscience Ownership | Who Owns Alto Neuroscience?


OverviewForecastRevenueFinancialsChart

Alto Neuroscience Ownership Summary


Alto Neuroscience is owned by 5.52% institutional investors, 6.52% insiders, and 87.96% retail investors. Alpha wave global, lp is the largest institutional shareholder, holding 13.70% of ANRO shares.

ANRO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlto Neuroscience5.52%6.52%87.96%
SectorHealthcare Stocks 41.87%10.80%47.33%
IndustryBiotech Stocks 43.97%10.75%45.28%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Alpha wave global, lp3.71M13.70%$14.91M
Armistice capital1.64M6.04%$6.58M
Point72 asset management1.33M4.92%$5.36M
Franklin resources1.16M4.29%$4.67M
Vanguard group1.11M4.08%$4.44M
Vestal point capital, lp950.00K3.51%$3.82M
Marshall wace, llp825.23K3.05%$3.32M
72 investment667.78K2.47%$2.68M
Alkeon capital management477.10K1.76%$1.92M
Northern trust461.29K1.70%$1.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
72 investment667.78K3.95%$2.68M
Alpha wave global, lp3.71M1.51%$14.91M
Peapod lane capital281.96K1.02%$1.14M
Almitas capital195.15K0.18%$784.48K
Vestal point capital, lp950.00K0.17%$3.82M
Integral health asset management400.00K0.11%$1.61M
Awm investment company280.48K0.11%$1.13M
Armistice capital1.64M0.10%$6.58M
Ikarian capital110.00K0.04%$442.20K
Orbimed advisors250.00K0.02%$1.00M

Top Buyers

HolderShares% AssetsChange
Perceptive advisors155.37K0.02%155.37K
Two sigma investments, lp116.58K0.00%71.84K
Two sigma advisers, lp149.90K0.00%67.70K
Renaissance75.77K0.00%41.07K
Bridgeway capital management77.65K0.01%23.55K

Top Sellers

HolderShares% AssetsChange
Woodline partners lp---359.87K
Ubs group139.03K0.00%-289.19K
Blackrock funding, inc. /de367.88K--193.97K
Charles schwab investment management---115.26K
Marshall wace, llp825.23K0.00%-112.18K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors155.37K0.02%155.37K$624.57K
Xtx topco15.75K0.00%15.75K$63.30K
Northwestern mutual wealth management1.45K-1.45K$5.83K
North star investment management174.00-174.00$699.00
Srs capital advisors42.00-42.00$169.00

Sold Out

HolderChange
Sterling capital management-161.00
Clearstead advisors-178.00
Nelson, van denburg & campbell wealth management group-249.00
Wells fargo & company/mn-351.00
Physician wealth advisors-377.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202517-78.48%1,494,416-91.36%50.14%9-78.57%5-76.19%
Jun 30, 202579-7.06%17,296,404-16.08%631.10%427.69%21-16.00%
Mar 31, 2025867.50%20,845,493-6.06%771.14%39-23.53%26100.00%
Dec 31, 202481-5.81%22,530,140-1.78%831.15%52-21.21%1344.44%
Sep 30, 20248648.28%22,939,57423.33%851.79%6669.23%9-10.00%

Recent Insider Transactions


DateNameRoleActivityValue
Jul 10, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$38.75K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$18.25K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$133.83K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q33-

ANRO Ownership FAQ


Who Owns Alto Neuroscience?

Alto Neuroscience shareholders are primarily institutional investors at 5.52%, followed by 6.52% insiders and 87.96% retail investors. The average institutional ownership in Alto Neuroscience's industry, Biotech Stocks , is 43.97%, which Alto Neuroscience falls below.

Who owns the most shares of Alto Neuroscience?

Alto Neuroscience’s largest shareholders are Alpha wave global, lp (3.71M shares, 13.70%), Armistice capital (1.64M shares, 6.04%), and Point72 asset management (1.33M shares, 4.92%). Together, they hold 24.66% of Alto Neuroscience’s total shares outstanding.

Does Blackrock own Alto Neuroscience?

BlackRock is not among the top 10 institutional shareholders of Alto Neuroscience.

Who is Alto Neuroscience’s biggest shareholder by percentage of total assets invested?

72 investment is Alto Neuroscience’s biggest shareholder by percentage of total assets invested, with 3.95% of its assets in 667.78K Alto Neuroscience shares, valued at 2.68M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools